FDA 510K Consultants, Guidance & Submissions

Experienced FDA Compliance Counsel for 510(k) Premarket Submissions

The U.S. Food and Drug Administration (FDA) regulates medical devices manufactured and sold in the United States under a comprehensive regulatory framework. While certain new medical devices are subject to premarket approval (PMA), a significant number of devices are introduced to the market through a less burdensome route: the premarket notification process, commonly referred to as a 510(k) submission. Governed by Section 510(k) of the Food, Drug, and Cosmetic Act (FD&C Act), this process primarily applies to class II devices, although Class III medical devices were once eligible until the FDA required a more rigorous pathway.

Despite its relative efficiency compared to PMA, the 510(k) submission process presents a number of complexities. Companies must not only identify a predicate device but also demonstrate that the new product is substantially equivalent in terms of intended use and technological characteristics. At Oberheiden P.C., our team of FDA 510k consultants, many with prior FDA or federal agency experience, provides tailored guidance for each step of the submission process and handles communications with the FDA directly on behalf of our clients.

What Medical Device Companies Must Know About Section 510(k)

Section 510(k) facilitates a route to market for qualifying medical device companies without undergoing the extensive PMA. However, achieving “FDA clearance” under this path requires thorough preparation. Device manufacturers must prove that the new device is substantially equivalent to a legally marketed device (known as a predicate). This comparison must satisfy one of two criteria:

1. The new device has the same intended use and same technological characteristics as the predicate; or
2. The new device has the same intended use but different technological characteristics that do not raise new concerns about the device’s safety or effectiveness and demonstrate that it is as safe and effective as the predicate.

Importantly, the FDA ultimately makes the substantial equivalence determination. Without the agency’s favorable review, the device cannot be legally marketed.

If the FDA determines the device is not substantially equivalent, the manufacturer must pursue alternative options, including:

• Submitting a new 510(k) submission with additional clinical data;
• Requesting classification through the de novo process (typically for Class I or II);
• Filing a reclassification petition;
• Pursuing full premarket approval.

Each of these options imposes significant time, cost, and risk. For that reason, our attorneys emphasize establishing a strong foundation in regulatory strategy and quality system regulation from the outset.

Three Types of FDA 510(k) Submissions

To accommodate varying circumstances, the FDA offers three premarket notification pathways for 510(k) compliance:

1. Traditional 510(k) Compliance

This is the most common and flexible route and can be used in virtually any scenario. A traditional 510(k) must include all required information under 21 CFR 807.87, including:

• Device description;
• Identification of a previously cleared device;
• Comparative analysis demonstrating substantial equivalence;
• Test protocols, validation testing, and test reports;
• Performance data, including bench testing, electromagnetic compatibility, and biocompatibility testing if relevant.

This process also includes information about manufacturing processes, financial certification, and commercial distribution plans.

2. Special 510(k) Compliance

The Special 510(k) is intended for manufacturers modifying their own cleared devices. The assumption is that the manufacturer is familiar with the device specifications and intended use. This path typically requires:

• Application of relevant FDA guidance;
• Consideration of any recognized consensus standards;
• Use of the electronic submission template.

Our team assists clients in confirming whether changes to the device type meet the eligibility criteria for a Special 510(k).

3. Abbreviated 510(k) Compliance

The Abbreviated 510(k) path leverages existing FDA guidance and recognized standards. Submissions often include:

• A “declaration of conformity” to standards as per the FDA guidance document titled “Appropriate Use of Voluntary Consensus Standards”;
• Inclusion of summary reports and acceptance criteria;
• Consideration of software validation, animal testing, and patient contact factors where applicable.

Our legal team supports all three forms of 510(k) submissions, beginning with an assessment of your regulatory pathway and advancing through every step of the review process.

FAQs: FDA 510(k) Compliance for Medical Devices

Managing the FDA 510(k) Submission Process Effectively

Given the scope and detail involved in preparing a successful 510(k), strategic legal counsel is essential. At Oberheiden P.C., our attorneys work closely with clients to:

• Develop and refine submission packages;
• Structure clinical and bench testing programs;
• Ensure compliance with device classification regulation chapters;
• Support interactions through pre-submission process channels;
• Provide updates throughout the clearance process.

From specification developers to operations, our comprehensive legal support ensures that no element is overlooked. Whether your device uses fundamental scientific technology or advanced digital components, our team ensures every detail meets regulatory expectations.

Speak with an FDA 510(k) Consultant at Oberheiden P.C.

For strategic advice and legal support regarding 510(k) submissions, contact Oberheiden P.C. Our experienced attorneys and FDA consultants provide end-to-end assistance with device substantially equivalent analysis, submission preparation, and post-submission dialogue with regulators.

Call 888-680-1745 today to schedule a free consultation and learn how we help medical device manufacturers achieve regulatory compliance and FDA clearance.